16 pharmaceutical companies were selected in the 2020 Beijing "special new" small and medium-sized enterprises list.

"Pharmaceutical Network Industry Dynamics" Recently the Beijing Municipal Economic and Information Technology Commission announced the "Annual Beijing Special New" Small and Medium-sized Enterprises list a total of enterprises were selected to be awarded the "Special New" certification"Special and new" that is, specialization, refinement, characteristic, noveltyIn accordance with the "guidance on promoting the development of beijing's small and medium-sized enterprises", "special and new" requirements of the Beijing Municipal Bureau of Economy and Information Technology to organize the first batch of Beijing "special new" small and medium-sized enterprises selection workIt is reported that the selection comprehensively examined the declaration of enterprises in economic efficiency, specialization, innovation ability and management indicators require enterprises in the market segment to be the best representative of the industry's leading innovation capabilities, master the key core technologies in the fieldFrom the list of industry classification, many concentrated in the field of in vitro diagnosis, medicine, biologyAmong them, the pharmaceutical field according to the author incomplete combing including Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., Ltd., Beijing Oriental Baitai Biotech Co., Ltd., Beijing Kangchen Pharmaceutical Co., Ltd., Beijing Noconda Pharmaceutical Technology Co., Ltd., Beijing Kangrentang Pharmaceutical Co., Ltdand other enterprises are on the listMany of them have been awarded the "special new" certification of pharmaceutical companies focused on ZhongguancunFor example, Beijing Oriental Baitai Biotech Co., Ltdis located in Zhongguancun Yimanor District is an innovative antibody research and development and production of high-tech enterprises to major disease treatment and preventive biomedicine productsThe company has hundreds of professional antibody research and development team to build a high level, research and production of the whole through the original antibody drugs and new vaccine-based industrialization technology platformIn the oncology, diabetes, autoimmune diseases and other aspects of the development pipeline layout for China's major diseases prevention and treatment, as well as to enhance China's biopharmaceutical innovation capacity and industrialization of the rapid development to make outstanding contributionsYangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., Ltdis located in Zhongguancun Life Science ParkThe company is the northern bridgehead for Yangzijiang Pharmaceutical Group is the Beijing Respiratory Disease Drug Engineering Technology Research CenterNot long ago, Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., Ltd was also selected as "Beijing Integrity To Create Enterprises." It is reported that this is the company since the beginning of the successful declaration of the sixth consecutive year through the review of the award Kangchen Pharmaceuticals is also located in Beijing Changping District Zhongguancun Life Science park was founded in the year and in the year to complete the stock board listed companies currently have a listed national class of new drugs - Su Ling At the same time own, many in the research of the country a class of new drugs won the national plan, the national torch plan and many other honors After years of new drug creation and the actual history of Kangchen Pharmaceuticals has accumulated a wealth of experience in innovative drug research and development From topic research, product screening, preclinical research, clinical research registration declaration, industrialization conversion to clinical re-research after product market In addition, the company also established a complete research and development system and platform and cultivate a international standard, mature and stable research and development team for Kangchen Pharmaceuticals new drug creation and continuous success to provide a strong guarantee